ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Pinedo To Receive Josef Steiner Prize; Lurie Cancer Center Gets $2.5M Donation

October 27, 1995

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

Bush Appoints Kripke To President’s Cancer Panel

February 21, 2003

Treatment IND or GM-CSF Is Approved

October 5, 1990

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005